PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
10-Nov-2023 Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Gemcitabine and Cisplatin as First-Line Treatment for Locally Advanced Unresectable or Metastatic Biliary Tract Cancer Businesswire
10-Nov-2023 JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA Businesswire
10-Nov-2023 JCR Pharmaceuticals Announces First Patient Dosed in a Global Phase I/II Clinical Trial of JR-441 for the Treatment of MPS IIIA Businesswire
10-Nov-2023 FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma Businesswire
10-Nov-2023 Imvax to Present New Data on Lead Program, IGV-001, at 2023 SNO Annual Meeting Businesswire
10-Nov-2023 4Moving Biotech forms its Scientific Advisory Board of World-Renowned Knee Osteoarthritis Experts Businesswire
10-Nov-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
10-Nov-2023 Takeda recibe la aprobación de la FDA de EE. UU. del FRUZAQLA™ (fruquintinib) para el cáncer colorrectal metastásico previamente tratado Businesswire
10-Nov-2023 Takeda erhält US-Zulassung der FDA für FRUZAQLA™ (Fruquintinib) zur Behandlung von metastasiertem Dickdarmkrebs Businesswire
10-Nov-2023 Cencora Announces Common Share Repurchase From Walgreens Boots Alliance Businesswire
10-Nov-2023 OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event Businesswire
10-Nov-2023 Thermo Fisher Scientific Declares Quarterly Dividend Businesswire
10-Nov-2023 Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Businesswire
10-Nov-2023 Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results Businesswire
10-Nov-2023 Takeda obtient l’approbation de la FDA des États-Unis pour le FRUZAQLA™ (fruquintinib) dans le traitement du cancer colorectal métastatique déjà traité Businesswire
10-Nov-2023 Model N Announces Fourth Quarter and Fiscal Year 2023 Financial Results Businesswire
10-Nov-2023 Aura Biosciences Reports Third Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights Businesswire
10-Nov-2023 MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights Businesswire
10-Nov-2023 Omeros Corporation Reports Third Quarter 2023 Financial Results Businesswire
10-Nov-2023 Akili Reports Third Quarter 2023 Financial Results and Provides Business Update Businesswire